Researchers develop method to monitor transplanted cells

03/8/2012 | MolecularImaging.net

NIH researchers have developed a magnetic resonance imaging method to monitor how stem cells function once transplanted. The method consists of two FDA-approved drugs that can attach to cells and a third that is detectable by MRI. The technique is being tested in brain tumor patients who receive transplants of engineered neural stem cells.

View Full Article in:

MolecularImaging.net

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY